Details of the Drug Reposition

General Information of This Drug (ID: DMRV7T7)

Drug Name
ATIR101   DMRV7T7
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myelodysplastic syndrome DISYHNUI 2A37 Phase 3 [1]
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 3 [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02999854) Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer (HATCY). U.S. National Institutes of Health.